1-(4-Bromophenyl)-3-(4-(3-chlorophenyl)piperazin-1-yl)propan-1-one

Catalog No. :
ACQZRR700
CAS No. :
952182-60-4
Molecular Formula :
C19H20BrClN2O
Molecular Weight :
407.74

IUPAC Name:1-(4-bromophenyl)-3-(4-(3-chlorophenyl)piperazin-1-yl)propan-1-one

1-(4-Bromophenyl)-3-(4-(3-chlorophenyl)piperazin-1-yl)propan-1-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
10mg95%$72.00Login to see priceInquiryInquiry
1g95%$166.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(4-Bromophenyl)-3-(4-(3-chlorophenyl)piperazin-1-yl)propan-1-one
IUPAC Name1-(4-bromophenyl)-3-(4-(3-chlorophenyl)piperazin-1-yl)propan-1-one
MDL No.MFCD05261306
Molecular FormulaC19H20BrClN2O
Molecular Weight407.74
SMILESO=C(C1=CC=C(Br)C=C1)CCN2CCN(C3=CC=CC(Cl)=C3)CC2
InChI KeyLNIWYOFBBBDUOU-UHFFFAOYSA-N
Synonym1-(4-BROMOPHENYL)-3-[4-(3-CHLOROPHENYL)PIPERAZINO]-1-PROPANONE;1-Propanone, 1-(4-bromophenyl)-3-[4-(3-chlorophenyl)-1-piperazinyl]-
CAS No.952182-60-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACQZRR700 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACLYJF051 route compound structure diagram
    ACLYJF05199-90-1 In Stock
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACQZRR700 route product structure diagram
    ACQZRR700952182-60-4
Inquiry

2. ACQZRR700 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACQZRR700 route product structure diagram
    ACQZRR700952182-60-4
Inquiry

Comments (0)